Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries Ltd Recommend Dividend And Bonus Issue


Tuesday, 28 May 2013 06:32am EDT 

Sun Pharmaceutical Industries Ltd announced that he Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has recommended payment of dividend of INR5 (Rupees Five) per equity share of INR1 each of the Company (pre bonus as recommended as below) for the year ended March 31, 2013 subject to the approval of the members at the ensuing Annual General Meeting of the Company. Further the Company has informed that, the Board decided to recommend the issue of Bonus Equity shares of INR1 each subject to the receipt of approval of the equity shareholders of the Company, to the equity shareholders of the Company in the ratio of 1 (One) equity share for every 1 (One) No. of equity shares held by the equity shareholders in the Company, as on the record date to be fixed by the Board after receiving approval from the shareholders for issue of such bonus shares. 

Company Quote

809.25
-2.75 -0.34%
19 Dec 2014